Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 68

Daily Deal Round Up: November 4, 2021

Ubicom Holdings Japan helped gynaecological imaging software developer Illumigyn take its total funding to $33m while Optum took part in a $30m round for health payment technology provider Medallion.

Nov 4, 2021

HoneyBook tells story of $250m series E

The business management software developer hiked its overall funding to $465m and its valuation to $2.4bn in a Citi Ventures-backed round.

Nov 4, 2021

Cross River starts Digital Ventures unit

Hillel Olivestone, Cross River’s head of corporate development, will run unit.

Nov 4, 2021

Daily Deal Round Up: November 3, 2021

Cox Enterprises invested in digital media company Axios at a $430m valuation while Bristol Myers Squibb helped enzyme drug developer Nitrase Therapeutics boost its series A round to $45m.

Nov 3, 2021

Nubank files for dual listing

The Tencent and Berkshire Hathaway-backed digital bank is seeking to grow its valuation from $30bn in June to over $50m in flotations in the US and Brazil.

Nov 3, 2021

Chipper Cash receives $250m funding transfer

FTX helped Chipper add $150m to a series C round valuing the cross-border payment platform developer at over $2bn.

Nov 3, 2021

Daily Deal Round Up: November 2, 2021

Corporate-backed financial remittance network operator Lightnet netted over $48m while Callaway Golf Company invested $30m in indoor golfing chain Five Iron Golf.

Nov 2, 2021

Corporates dig out $700m for DCG shares

SoftBank’s Vision Fund 2 and Latin America Fund co-led a secondary round for the blockchain-focused investment group at a $10bn valuation, participating with fellow corporate Alphabet’s CapitalG unit.

Nov 2, 2021

RecargaPay tops up series C to $80m

The mobile payment app developer has expanded an Experian-backed round with a $10m extension, taking its total funding to approximately $110m.

Nov 2, 2021

Daily Deal Round Up: November 1, 2021

Cell therapy developer Hopstem completed a $40m Eli Lilly-backed series B round while cybersecurity technology developer SlashNext secured $26m from investors including Telia and Ayala Group.

Nov 1, 2021
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here